FDA Inspection 1236268 — Liana Apostolova, M.D.

Liana Apostolova, M.D. — FEI 3030150704

The FDA completed an inspection of Liana Apostolova, M.D. on Apr 18, 2024 in Indianapolis, IN. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 3 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Apr 18, 2024
Fiscal Year
2024
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Indianapolis, IN (United States)

Additional Details

Sponsor-Investigator (S-I)

Citations

IDCFRDescription
745921 CFR 312.57(a)Records of receipt, shipment, disposition
748021 CFR 312.50Ensuring compliance with plan and protocol
756021 CFR 312.60FD-1572, protocol compliance